Pharmacokinetic and pharmacodynamic evaluation of elosulfase alfa, an enzyme replacement therapy in patients with Morquio A syndrome (Q34567469)

2

1 reference

3 August 2017

Becky Schweighardt

3

1 reference

3 August 2017

Troy Tompkins

4

1 reference

3 August 2017

Lynne Jesaitis

5

1 reference

3 August 2017

Adam J Shaywitz

6

1 reference

3 August 2017

Ke Yang

7

1 reference

3 August 2017

Charles A O'Neill

Clinical Pharmacokinetics

8

1 reference

3 August 2017

1 December 2014

1 reference

3 August 2017

1 reference

3 August 2017

53

1 reference

3 August 2017

1137-1147

1 reference

3 August 2017

12

1 reference

3 August 2017

Creative Commons Attribution-NonCommercial 4.0 International

start time

19 September 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s40262-014-0173-y

0 references

cites work

Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4243006

Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4243006

Enzyme replacement in a human model of mucopolysaccharidosis IVA in vitro and its biodistribution in the cartilage of wild type mice

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4243006

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4243006

Incidence of the mucopolysaccharidoses in Northern Ireland

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4243006

Overexpression of the human lysosomal enzyme alpha-L-iduronidase in Chinese hamster ovary cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4243006

The Morquio A Clinical Assessment Program: baseline results illustrating progressive, multisystemic clinical impairments in Morquio A subjects.

7 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS40262-014-0173-Y

International Morquio A Registry: clinical manifestation and natural course of Morquio A disease.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS40262-014-0173-Y

Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-ac

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS40262-014-0173-Y

Incidence of the mucopolysaccharidoses in Western Australia

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25234648